Immunologic approach to cancer therapy.

Area of Science:

• Oncology
• Immunology

Background:

• Cancer patients exhibit resistance to disease progression, evidenced by spontaneous regressions in various cancers (e.g., neuroblastoma, malignant melanoma).
• Long-term dormancy of metastases after primary tumor removal suggests underlying host defense mechanisms are at play.

Purpose of the Study:

• To explain the observed resistance in cancer patients through host defense mechanisms.
• To review historical immunotherapy approaches in cancer treatment.
• To present novel directions for future immunotherapy research.

Main Methods:

• Review of documented cases of spontaneous cancer regression.
• Analysis of long-term metastasis dormancy.
• Literature review of historical and emerging immunotherapy strategies.

Main Results:

• Host defense mechanisms are identified as the primary explanation for cancer patient resistance.
• Documented cases of spontaneous regressions and dormant metastases support the role of host immunity.
• A historical overview of immunotherapy efforts highlights evolving strategies.

Conclusions:

• Host immune responses are critical in controlling cancer progression and enabling spontaneous regressions.
• Understanding these defense mechanisms is key to developing effective immunotherapies.
• Future research should focus on novel immunotherapy directions to harness the host's anti-cancer potential.